Project Grant K76AG083304
Award Date
9/1/24
Completion Date
5/31/29
Dollars Obligated
$243K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84132, USA
Similar Awards
The U.S. Department of Health and Human Services (HHS) Agency for Healthcare Research and Quality (AHRQ) awarded a 4-year, $500,000 Project Grant under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program to Brigham & Women's Hospital Inc. in Boston, MA. The grant aims to leverage electronic health record (EHR) data and stakeholder expertise to gain an understanding of risk factors, disparities, and outcomes related to delayed diagnosis of venous thromboembolism (VTE)...
This Project Grant award from the National Institute on Aging's Aging Research Program (CFDA 93.866) provides $2,573,724 to Tulane University to investigate the role and therapeutic potential of the protein perlecan in vascular dementia (VAD). The research aims to determine how age, sex, and environmental factors like hypoxia influence perlecan levels, its cleavage by cathepsin B, and the impact on pericyte coverage and blood-brain barrier integrity - key factors in the development of VAD. The...
The University of Texas Health Science Center at Houston (UTHealth) received a $1,238,672 federal Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866) with an award date of September 1, 2023. The grant supports research to examine the pathological role of von Willebrand factor (VWF) within the wall of leptomeningeal arteries and arterioles, and its potential to impair cerebrovascular function and vascular-mediated clearance of amyloid-beta...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $3,007,209 Project Grant under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) to The University of Texas Health Science Center at Tyler. The grant, awarded on July 15, 2024, will fund research to elucidate the role of GAB2-MALT1-mediated cell signaling in venous thrombogenesis and the development of venous thromboembolism (VTE), which is a major...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $234,000.00 to the University of Colorado-Denver to develop and pilot a patient decision aid (DA) to support shared decision-making between clinicians, patients, and caregivers regarding pharmacologic therapies for dementia. The key objectives are to conduct a qualitative needs assessment among patients, caregivers, and clinicians, and then use an iterative, user-centered approach to develop and...
This National Institute of Child Health and Human Development (NICHD) Project Grant award (CFDA 93.865 - Child Health and Human Development Extramural Research) is providing $137,970 to the University of Utah from August 15, 2024, to July 31, 2029, to conduct research aimed at characterizing longitudinal post-acute rehabilitation (PAR) utilization and outcomes during the first year after stroke in Medicare beneficiaries. The key objectives of this research project are to: 1) identify subgroups...
This federal Project Grant award of $625,835 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to optimize aerobic fitness and functional response to exercise in older adults. The primary awardee, the University of Vermont, will evaluate the efficacy of a combined high-intensity interval aerobic training (HIIT) and high-intensity resistance training (HIRT) intervention compared to standard moderate-intensity aerobic and resistance training to improve...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $308,000 to the University of Utah to study patient-reported outcomes for older adults with carotid artery stenosis. The project aims to identify reliable measures of non-stroke symptoms like cognitive decline, sleep issues, and mood changes that may occur with carotid artery disease, both with and without surgical treatment. Research activities include administering standardized...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will provide $198,720 to The Johns Hopkins University to conduct research on functional fibrinolysis, thromboinflammation, and venous thromboembolism (VTE) risk for ventilated children. The key objectives are to: 1) determine the impact of invasive mechanical ventilation (IMV) intensity on functional fibrinolysis; 2) identify plasma biomarkers...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $460,625 to the University of Massachusetts Medical School to investigate the role of platelets and the necroptosis pathway in age-related thrombotic complications from respiratory viral infections like influenza and COVID-19. The key objectives of this 2-year research project are to: 1) Determine how influenza virus infection and age impact platelet necroptosis and cytoplasmic content release,...